Moix F M, Raufman J P
University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Clin Cornerstone. 2001;3(6):13-23. doi: 10.1016/s1098-3597(01)90075-4.
Percutaneous liver biopsy, first performed by Paul Ehrlich in 1883, remains an important diagnostic procedure for the management of hepatobiliary disorders. Modern biochemical, immunologic, and radiographic techniques have facilitated the diagnosis of liver disease but have not made biopsy obsolete. Indeed, examination of liver histology remains the "gold standard" for many diagnoses. This article reviews current indications for liver biopsy and the role biopsy plays in managing a variety of disorders.
经皮肝活检由保罗·埃尔利希于1883年首次实施,至今仍是肝胆疾病管理中的一项重要诊断程序。现代生化、免疫和影像学技术促进了肝病的诊断,但并未使活检过时。事实上,肝组织学检查仍是许多诊断的“金标准”。本文综述了当前肝活检的适应证以及活检在多种疾病管理中的作用。